Women's Health
Session # n/a
Genetic testing laboratories accumulate large amounts of clinical data from clinicians via test requisition forms (TRFs) and clinical documents such as pedigrees and/or detailed clinic notes (‘clinicals’). When curated, phenotype data such as tumor site, histology, and age of diagnosis (dx) can be used in variant assessment, genetic disease characterization, and clinical research; however, the use of phenotype derived from TRFs is often questioned. The purpose of this study is to evaluate the completeness and accuracy of ovarian and uterine cancer data from TRFs among patients undergoing hereditary cancer multigene panel testing (MGPT).